Get started
Author

Gajalakshmi Singuru

Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation
2023 · Sriravali Pulipaka, Gajalakshmi Singuru, et al. · GeroScience · 35
DOT1L regulates MTDH ‐mediated angiogenesis in triple‐negative breast cancer: intermediacy of NF‐κB‐HIF1α axis
2022 · Praveen Kumar Neeli, Shashikanta Sahoo, et al. · FEBS Journal · 25
Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis
2024 · Sriravali Pulipaka, Hridya Chempon, et al. · Mechanisms of Ageing and Development · 23
Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis
2023 · Gajalakshmi Singuru, Sriravali Pulipaka, et al. · International Immunopharmacology · 11
A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent
2021 · Altab Shaikh, Praveen Kumar Neeli, et al. · Chemical Communications · 9
Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db/db mice
2024 · Gajalakshmi Singuru, Sriravali Pulipaka, et al. · Journal of Molecular Medicine · 7
Correction to: Therapeutic efficacies of mitochondria‑targeted esculetin and metformin in the improvement of age‑associated atherosclerosis via regulating AMPK activation
2023 · Sriravali Pulipaka, Gajalakshmi Singuru, et al. · GeroScience · 1
PDF
Author response for " DOT1L regulates MTDH mediated angiogenesis in triple‐negative breast cancer: Intermediacy of NF‐κB‐HIF1α axis"
2022 · Praveen Kumar Neeli, Shashikanta Sahoo, et al.
Works count: 8
Citation count: 109
H-index: 6
I10-index: 4
Year
Topic
Type